Camp4 Therapeutics (CAMP) Receivables - Other (2023 - 2025)

Camp4 Therapeutics (CAMP) reported Receivables - Other of $100000.0 for Q2 2025, little changed sequentially from $100000.0 in Q1 2025.

Camp4 Therapeutics (CAMP) Receivables - Other (2023 - 2025) Analysis & Trends

Camp4 Therapeutics (CAMP) has 3 years of Receivables - Other data on file, last reported at $100000.0 in Q2 2025.

For the quarter ending Q2 2025, Receivables - Other changed N/A year-over-year to $100000.0; the trailing twelve-month figure through Jun 2025 stood at $100000.0 (changed N/A YoY), and the FY2024 full-year result was $100000.0, changed 0.0% from the prior year.
Receivables - Other held at $100000.0 in Q2 2025, from $100000.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $100000.0 in Q4 2023 to a low of $100000.0 in Q4 2023.
A 3-year average of $100000.0 and a median of $100000.0 in 2023 frame the typical range for Receivables - Other.
Peak annual rise in Receivables - Other reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
Tracing CAMP's Receivables - Other over 3 years: stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
Business Quant data shows CAMP's Receivables - Other at $100000.0 in Q2 2025, $100000.0 in Q1 2025, and $100000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Camp4 Therapeutics	174.35 Mn	174.35 Mn	-

Download Data